Use of pharmaceutical nanotechnology for the treatment of leishmaniasis

Use of pharmaceutical nanotechnology for the treatment of leishmaniasis

Abstract INTRODUCTION: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects. METHODS: This study investigat...

Full description

Bibliographic Details
Main Authors: Carine Santana Ferreira Marques, Jorge Barreto Machado Júnior, Lucas Rannier de Melo Andrade, Luciana Nalone Andrade, André Luis Souza dos Santos, Maria do Socorro Pires e Cruz, Marco Chaud, Alini Tinoco Fricks, Patrícia Severino
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2019-04-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Leishmaniasis
Drugs
Nanotechnology
Treatment
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100636&lng=en&tlng=en
Description
Summary:Abstract INTRODUCTION: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects. METHODS: This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis. RESULTS: Our findings revealed a stable number of patents and scientific articles published over the past five years. CONCLUSIONS: There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.
ISSN:1678-9849

Similar Items